Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Norio Hamamatsu is active.

Publication


Featured researches published by Norio Hamamatsu.


Applied Microbiology and Biotechnology | 2006

Modified substrate specificity of pyrroloquinoline quinone glucose dehydrogenase by biased mutation assembling with optimized amino acid substitution

Norio Hamamatsu; Akitoshi Suzumura; Yukiko Nomiya; Masaaki Sato; Takuyo Aita; Motowo Nakajima; Yuzuru Husimi; Yasuhiko Shibanaka

A biased mutation-assembling method—that is, a directed evolution strategy to facilitate an optimal accumulation of multiple mutations on the basis of additivity principles, was applied to the directed evolution of water-soluble PQQ glucose dehydrogenase (PQQGDH-B) to reduce its maltose oxidation activity, which can lead to errors in blood glucose determination. Mutations appropriate for the reduction without fatal deterioration of its glucose oxidation activity were developed by an error-prone PCR method coupled with a saturation mutagenesis method. Moreover, two types of incorporation frequency based on their contribution were assigned to the mutations: high (80%) and evens (50%), in constructing a multiple mutant library. The best mutant created showed a marked reduction in maltose oxidation activity, corresponding to 4% of that of the wild-type enzyme, with 35% retention of glucose oxidation activity. In addition, this mutant showed a reduction in galactose oxidation activity corresponding to 5% of that of the wild-type enzyme. In conclusion, we succeeded in developing the PQQGDH-B mutants with improved substrate specificity and validated our method coupled with optimized mutations and their contribution-based incorporation frequencies by applying it to the development.


Archive | 2012

Dual function proteins for treating metabolic disorders

Brian R. Boettcher; Shari L. Caplan; Susan E. Cellitti; Douglas S. Daniels; Norio Hamamatsu; Bernhard H. Geierstanger; Stuart Licht; Andreas Loew; Stephen Craig Weldon


Archive | 2012

Fusion proteins for treating metabolic disorders

Brian R. Boettcher; Shari L. Caplan; Douglas S. Daniels; Norio Hamamatsu; Stuart Licht; Stephen Craig Weldon


Archive | 2011

Methods of treating FGF21-associated disorders

Brian R. Boettcher; Shari L. Caplan; Douglas S. Daniels; Bernhard H. Geierstanger; Norio Hamamatsu; Stuart Licht; Andreas Loew; Stephen Craig Weldon


Biopolymers | 2002

Surveying a local fitness landscape of a protein with epistatic sites for the study of directed evolution

Takuyo Aita; Norio Hamamatsu; Yukiko Nomiya; Hidefumi Uchiyama; Yasuhiko Shibanaka; Yuzuru Husimi


Protein Engineering Design & Selection | 2005

Biased mutation-assembling: an efficient method for rapid directed evolution through simultaneous mutation accumulation.

Norio Hamamatsu; Takuyo Aita; Yukiko Nomiya; Hidefumi Uchiyama; Motowo Nakajima; Yuzuru Husimi; Yasuhiko Shibanaka


Protein Engineering Design & Selection | 2006

Directed evolution by accumulating tailored mutations: Thermostabilization of lactate oxidase with less trade-off with catalytic activity

Norio Hamamatsu; Yukiko Nomiya; Takuyo Aita; Motowo Nakajima; Yuzuru Husimi; Yasuhiko Shibanaka


Archive | 2004

PYRROLOQUINOLINE QUINONE-DEPENDENT GLUCOSE DEHYDROGENASE

Akitoshi Suzumura; Norio Hamamatsu


Archive | 2012

Fibroblast growth factor-21-Fc fusion proteins

Brian R. Boettcher; Shari L. Caplan; Douglas S. Daniels; Norio Hamamatsu; Stuart Licht; Stephen Craig Weldon


Archive | 2015

HSA-GDF-15 FUSION POLYPEPTIDE AND USE THEREOF

Rajiv Chopra; Norio Hamamatsu; Ryan S. Streeper; Brian Edward Vash

Collaboration


Dive into the Norio Hamamatsu's collaboration.

Researchain Logo
Decentralizing Knowledge